Exploiting mesothelin in thymic carcinoma as a drug delivery target for anetumab ravtansine.

Vincent ChenShigeki UmemuraYumin HanRenuka RamanRobin TuckerJoeffrey ChahineIn-Kyu KimChristoph SchatzSabine Zitzmann-KolbeAnette SommerMasanori OndaTrevor LeeYongfeng HeGiuseppe Giaccone

Published in: British journal of cancer (2021)

These data demonstrate that anetumab ravtansine inhibits the growth of MSLN positive thymic carcinoma cells in vitro and in vivo.

Keyphrases

drug delivery
electronic health record
cancer therapy
big data
machine learning
artificial intelligence
deep learning